Kusanishi Takako, Tanaka Naotake, Itoi Mizue, Ijiri Miwa, Ebisawa Keiko, Suzuka Kiyomi, Hagiwara Youko, Yonemoto Tukasa, Araki Akinobu, Itami Makiko
Department of Gynecology, Chiba Cancer Center, 666-2, Nitona-cho, Chuo-ku, Chiba 260-8717 Japan.
Department of Orthopedics, Chiba Cancer Center, 666-2, Nitona-cho, Chuo-ku, Chiba 260-8717 Japan.
Int Cancer Conf J. 2023 May 9;12(4):241-247. doi: 10.1007/s13691-023-00613-x. eCollection 2023 Oct.
Primary osteosarcoma of the uterus (uOS) is rare, and its standard treatment has not yet been established. Herein, we present the case of a 50-year-old woman with uOS who demonstrated an improved prognosis after multiple surgeries to the metastatic sites. After the initial diagnosis of uOS, the patient showed recurrence and distant metastasis and hence expected to exhibit a poor prognosis. The patient underwent multiple surgical resections of the metastatic as well as primary tumors, which enabled the patient to survive for 24 months after the initial surgery. Considering that the median survival time of patients with uOS is approximately 6 months, the survival rate of our patient is noteworthy. Based on our observations, it is suggested that the resection of the primary and metastatic tumors might contribute to the extension of the survival period of the patient with chemo-resistant uOS.
子宫原发性骨肉瘤(uOS)较为罕见,其标准治疗方案尚未确立。在此,我们报告一例50岁患有uOS的女性病例,该患者在对转移部位进行多次手术后预后得到改善。在uOS初步诊断后,患者出现复发和远处转移,因此预期预后较差。该患者接受了转移瘤和原发肿瘤的多次手术切除,使其在初次手术后存活了24个月。鉴于uOS患者的中位生存时间约为6个月,我们这位患者的生存率值得关注。基于我们的观察结果,提示对原发肿瘤和转移瘤的切除可能有助于延长化疗耐药性uOS患者的生存期。